Vita Coco Company, Inc. financial statements

Income statement, balance sheet and cash flow statement for the last 7 fiscal years, taken from the XBRL data Vita Coco Company, Inc. files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

	FY2019	FY2021	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	284	311	380	428	494	516	610
Cost of revenue	191	206	266	324	313	317	387
Gross profit	93	105	113	103	181	199	223
Research and development	0.64	0.31	0.48	0.54	0.42	0.4	0.4
Selling, general and administrative	78.9	74.4	88.6	100	124	125	140
Operating expenses	79.6	58	88.6	100	124	125	140
Operating income	13.4	46.9	24.6	3.06	56.5	73.8	82.5
Interest expense	1.16	0.79	0.36	0.26	0.03	0
Interest income	0.23	0.4	0.13	0.05	2.55	6.72	6.55
Other non-operating income	-1.97	-3.26	-0.36	7.79	1.43	-3.03	10.4
Pre-tax income	11.4	43.6	24.2	10.8	57.9	70.8	93
Income tax	1.98	10.9	5.24	3.03	11.3	14.8	21.7
Net income to minority interests	0.01	0.03	-0.02	0	0
Net income	9.42	32.7	19	7.81	46.6	56	71.3
EBITDA	15.5	49	26.7	4.96	57.2	74.6	83.6
EPS, basic	0.17	0.56	0.35	0.14	0.83	0.99	1.25
EPS, diluted	0.16	0.56	0.35	0.14	0.79	0.94	1.19
Shares, basic (weighted)	57	58.5	53.7	55.7	56.4	56.7	56.9
Shares, diluted (weighted)	57.2	58.6	54.2	56.1	58.7	59.3	60

Balance sheet

	FY2019	FY2021	FY2021	FY2022	FY2023	FY2024	FY2025
Cash and equivalents	36.7	72.2	28.7	19.6	133	165	197
Receivables		30.5	47.2	43.4	50.1	63.5	81.5
Inventory		32	75.4	84.1	50.8	83.6	111
Other current assets		23.1	20.7	22.2	24.2	27.2	30.2
Total current assets		159	173	175	263	341	421
Property, plant and equipment		2.88	2.47	2.08	2.14	2.35	9.3
Lease right-of-use assets			0	2.68	1.41	0.39	11.6
Goodwill		7.79	7.79	7.79	7.79	7.79	7.79
Intangible assets		9.15	7.93	0	0
Other non-current assets		1.96	1.95	1.68	1.84	2.21	2.71
Total assets		184	197	198	286	362	461
Accounts payable		15.8	28.3	15.9	21.8	30.8	25.5
Accrued liabilities		34.5	42.4	38.3	59.5	65.6	89.5
Total current liabilities		55.7	74	54.3	82.6	103	116
Long-term debt		0.03	0.05	0.03	0.01	0	0
Lease liabilities				2.05	0.44	0	13.1
Other non-current liabilities		0.48	0.3	2.29	0.65	0.3	0.1
Total liabilities		81.6	74.3	56.7	83.2	104	130
Paid-in capital		101	135	145	161	174	185
Retained earnings		28.4	47.4	55.2	101	157	228
Treasury stock		-8.93	-58.9	-58.9	-59.7	-71.7	-83
Other comprehensive income		-0.95	-0.62	-0.99	-0.65	-0.86	0.49
Shareholders' equity		102	123	141	202	259	332
Minority interests		0.08	0	0
Total equity	73.8	102	123	141	202	259	332
Total liabilities and equity		184	197	198	286	362	461
Shares outstanding		58.2	55.6	56	56.9	57	57.1

Cash flow statement

	FY2019	FY2021	FY2021	FY2022	FY2023	FY2024	FY2025
Net income	9.42	32.7	19	7.81	46.6	56	71.3
Depreciation and amortization	2.08	2.13	2.07	1.9	0.66	0.75	1.07
Stock-based compensation	2.23	1.52	3.38	7.38	9.13	8.92	10.8
Deferred income tax	-0.85	6.28	-1.62	-3.07	-2.49	0.64	-0.36
Change in receivables	-4.93	0.19	-16.9	0.32	-7.09	-14.2	-18.6
Change in inventory	11.1	4.98	-43.5	-9.33	33.7	-33	-27.3
Cash from operations	21.8	33.3	-16.2	-10.9	107	42.9	47.2
Capital expenditures	-1.01	-0.39	-0.56	-0.98	-0.6	-0.97	-8.15
Cash from investing	-1.01	-0.38	-0.56	-0.98	-0.59	-0.97	-8.25
Stock issued	0.03	0	0	3.06	7.09	3.75	3.75
Share buybacks	-0.04	-6.94	-50	0	-0.77	-12	-11.3
Cash from financing	-10.4	2.05	-26.8	3.03	6.29	-8.3	-7.53
Exchange rate effect	0.87	0.44	0.04	-0.18	0.39	-0.56	0.83
Net change in cash	11.3	35.4	-43.5	-9.06	113	33.1	32.2
Free cash flow	20.8	32.9	-16.7	-11.9	107	41.9	39
Interest paid	1.13	0.81	0.35	0.22	0.08	0	0
Income taxes paid	1.99	9.72	2.44	4.62	9.91	13	13.1

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to June 30, 2026; growth uses fiscal years. Valuation uses the share price of $58.59 on September 25, 2026.

Profitability

Metric	Value	How it is calculated
Gross margin	41.1%	Gross profit / revenue.
Operating margin	19.1%	Operating income / revenue.
EBITDA margin	19.3%	EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin	20.1%	Pre-tax income / revenue.
Net margin	15.5%	Net income / revenue.
FCF margin	17.6%	Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin	18.7%	Cash from operations / revenue.
Effective tax rate	23.0%	Income tax / pre-tax income, when pre-tax income is positive.
Return on equity (ROE)	27.3%	Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)	19.1%	Net income / average total assets.
Return on invested capital (ROIC)	84.9%	Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
SG&A / revenue	22.0%	Selling, general and administrative expense / revenue.
Stock-based pay / revenue	2.0%	Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue	1.0%	Capital expenditures / revenue.
D&A / revenue	0.2%	Depreciation and amortization / revenue.

Growth

Metric	Value	How it is calculated
Revenue growth, 1y	18.2%	Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y	12.5%	Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y	14.4%	Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y	12.0%	Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y	29.1%	Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y	16.2%	Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating income growth, 1y	11.8%	Operating income vs the same period a year earlier. Only from a positive base.
Operating income CAGR, 3y	200.1%	Compound annual growth of operating income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating income CAGR, 5y	12.0%	Compound annual growth of operating income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EBITDA growth, 1y	12.1%	EBITDA vs the same period a year earlier. Only from a positive base.
EBITDA CAGR, 3y	156.5%	Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EBITDA CAGR, 5y	11.3%	Compound annual growth of ebitda over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Net income growth, 1y	27.5%	Net income vs the same period a year earlier. Only from a positive base.
Net income CAGR, 3y	109.0%	Compound annual growth of net income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Net income CAGR, 5y	16.9%	Compound annual growth of net income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EPS growth, 1y	26.6%	EPS vs the same period a year earlier. Only from a positive base.
EPS CAGR, 3y	104.1%	Compound annual growth of eps over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EPS CAGR, 5y	16.3%	Compound annual growth of eps over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating cash flow growth, 1y	10.0%	Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 5y	7.2%	Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Free cash flow growth, 1y	-6.9%	Free cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow CAGR, 5y	3.5%	Compound annual growth of free cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value growth, 1y	28.1%	Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y	32.9%	Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y	26.5%	Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y	27.3%	Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y	32.6%	Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y	20.2%	Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y	1.1%	Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y	2.2%	Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y	0.5%	Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

Metric	Value	How it is calculated
Current ratio	3.36x	Current assets / current liabilities.
Quick ratio	2.58x	(Cash + short-term investments + receivables) / current liabilities.
Cash ratio	1.75x	(Cash + short-term investments) / current liabilities.
Liabilities / assets	30.0%	Total liabilities / total assets.
Working capital	$375.6M	Current assets - current liabilities.
Goodwill and intangibles / assets	1.4%	(Goodwill + intangible assets) / total assets.
Tangible book value	$393.1M	Shareholders' equity - goodwill - intangible assets.

Efficiency

Metric	Value	How it is calculated
Asset turnover	1.23x	Revenue / average total assets.
Fixed asset turnover	79.1x	Revenue / average property, plant and equipment.
Inventory turnover	5.01x	Cost of revenue / average inventory.
Days inventory	73 days	365 x average inventory / cost of revenue.
Receivables turnover	5.34x	Revenue / average receivables.
Days sales outstanding	68 days	365 x average receivables / revenue.
Days payables	27 days	365 x average accounts payable / cost of revenue.
Cash conversion cycle	114 days	Days inventory + days sales outstanding - days payables.
FCF conversion	113.7%	Free cash flow / net income, when net income is positive.
Capex / operating cash flow	5.5%	Capital expenditures / cash from operations, when that is positive.

Per share

Metric	Value	How it is calculated
EPS, diluted	$1.80	Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share	$11.64	Revenue / diluted weighted shares.
FCF per share	$2.05	Free cash flow / diluted weighted shares.
Operating cash flow per share	$2.17	Cash from operations / diluted weighted shares.
Book value per share	$6.98	Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share	$6.85	Tangible book value / shares outstanding.
Cash per share	$4.85	(Cash + short-term investments) / shares outstanding.
Buybacks / FCF	17.1%	Share buybacks / free cash flow, when free cash flow is positive.

Valuation

Metric	Value	How it is calculated
Market cap	$3.44B	Share price x shares outstanding.
Enterprise value	$3.16B	Market cap + total debt - cash - short-term investments.
P/E	31.4x	Market cap / net income. Only when net income is positive.
P/S	4.87x	Market cap / revenue.
P/B	8.58x	Market cap / shareholders' equity. Only when equity is positive.
Price / tangible book	8.75x	Market cap / tangible book value, when positive.
P/FCF	27.6x	Market cap / free cash flow. Only when free cash flow is positive.
P/OCF	26.1x	Market cap / cash from operations, when positive.
EV/Sales	4.48x	Enterprise value / revenue.
EV/EBIT	23.4x	Enterprise value / operating income, when both are positive.
EV/EBITDA	23.2x	Enterprise value / EBITDA, when both are positive.
EV/FCF	25.4x	Enterprise value / free cash flow, when both are positive.
FCF yield	3.6%	Free cash flow / market cap.
Earnings yield	3.2%	Net income / market cap (the inverse of P/E).
Shareholder yield	0.6%	(Dividends paid + share buybacks) / market cap.
PEG	0.30x	P/E / EPS growth per year over 3 years (in percent). Only when both are positive.

What was Vita Coco Company, Inc.'s revenue in fiscal 2025?

Vita Coco Company, Inc. reported revenue of $609.8M for fiscal 2025, 18.2% higher than the year before.

Was Vita Coco Company, Inc. profitable in fiscal 2025?

Yes. Net income was $71.3M, a net margin of 11.7%.

How much free cash flow did Vita Coco Company, Inc. generate in fiscal 2025?

Cash from operations of $47.2M minus capital expenditures of $8.1M left free cash flow of $39.0M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to Vita Coco Company, Inc.